Ocaliva Exit Could Help Ipsen And Gilead’s New Cholangitis Entrants

 
• By Andrew McConaghie
  
Gilead
Gilead and Ipsen/Genfit's products could benefit from an EU withdrawal of the drug. • Source: Shutterstock

More from New Products

More from Scrip